ASP Drug Pricing - (2nd Quarter)
April 2021
Payment Allowance Limits for Medicare Part B Drugs

  • Note 1: Payment allowance limits subject to the ASP methodology are based on Oct 2020 (4th Quarter) ASP data.
  • Note 2: The absence or presence of a HCPCS code and the payment allowance limits in this table does not indicate Medicare coverage of the drug. Similarly, the inclusion of a payment allowance limit within a specific column does not indicate Medicare coverage of the drug in that specific category. These determinations shall be made by the local Medicare contractor processing the claim.
 
Page 17 * Effective April 1, 2021 - June 30, 2021
HCPCS Code Code Dosage Payment
Limit		 Vaccine AWP % Vaccine Limit Infusion AWP % DME infusion limit Blood AWP % Blood limit Clotting factor Note
J7527 - Everolimus, oral, 0.25 mg 0.25 MG 6.693 - - - - - -
J7605 - Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms 15 mcg 10.662 - - - - - -
J7606 - Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms 20 MCG 11.017 - - - - - -
J7608 - Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram 1 GM 6.179 - - - - - -
J7611 - Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg 1 MG 0.283 - - - - - -
J7612 - Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg 0.5 MG 0.33 - - - - - -
J7613 - Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 1 MG 0.043 - - - - - -
J7614 - Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg 0.5 MG 0.059 - - - - - -
J7620 - Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 2.5 MG/0.5 MG 0.12 - - - - - -
J7626 - Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg 0.5 MG 1.462 - - - - - -
J7631 - Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams 10 MG 2.533 - - - - - -
J7639 - Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram 1 MG 47.794 - - - - - -
J7644 - Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram 1 MG 0.204 - - - - - -
J7674 - Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg 1 MG 0.804 - - - - - -
J7677 - Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram 1 MCG 0.189 - - - - - -
J7682 - Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams 300 MG 29.925 - - - - - -
J7686 - Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg 1.74 MG 671.307 - - - - - -
J8501 - Aprepitant, oral, 5 mg 5 MG 5.152 - - - - - -
J8520 - Capecitabine, oral, 150 mg 150 MG 0.74 - - - - - -
J8521 - Capecitabine, oral, 500 mg 500 MG 2.551 - - - - - -
J8530 - Cyclophosphamide; oral, 25 mg 25 MG 1.529 - - - - - -
J8540 - Dexamethasone, oral, 0.25 mg 0.25 MG 0.095 - - - - - -
J8560 - Etoposide; oral, 50 mg 50 MG 75.957 - - - - - -
J8610 - Methotrexate; oral, 2.5 mg 2.5 MG 0.222 - - - - - -
J8655 - Netupitant 300 mg and palonosetron 0.5 mg, oral 0.5 MG 304.129 - - - - - -
* Effective April 1, 2021 - June 30, 2021

Drugs not otherwise classified - April 2021

 

Medicare Part B payment allowance limits for drugs not otherwise classified - Effective April 1, 2021 - June 30, 2021

Drug name Dosage Payment limit Notes
Alfentanil Hcl 500 MCG 2.261
Allopurinol Sodium 500 MG 3203.906
Aminocaproic acid 250 MG 0.335
Aztreonam 500 MG 13.685
Bumetanide 0.25 MG 0.304
Bupivacaine 1 ML 0.087
Clindamycin Phosphate 150 MG 0.758
Coagulation Factor IX, Recombinant (Ixinity) 1 IU 2.21 includes clotting factor furnishing fee
Diltiazem Hydrochloride 5 MG 0.339
Doxycycline Hyclate 100 MG 19.508
Esmolol Hydrochloride 10 MG 0.271
Famotidine 10 MG 0.433
Flumazenil 0.1 MG 0.786
Folic Acid 5 MG 2.901
Glucarpidase 10 UNITS 345.176
Glycopyrrolate injection 0.2 MG 2.242
Immune Globulin (Cutaquig) 100 MG 16.437
Immune Globulin (Panzyga) 500 MG 62.292
Labetalol Hcl 5 MG 0.153
Metoprolol Tartrate 1 MG 0.145
Metronidazole inj 500 MG 1.194
Nitroglycerin 5 MG 1.282
Olanzapine short acting intramuscular injection 0.5 MG 1.248
Paliperidone Palmitate (Invega Trinza) 1 MG 10.19
Rabies Immune Globulin (Kedrab) 150 IU 258.074
Rifampin 600 MG 106.173
Sodium Chloride, Hypertonic (3% - 5% infusion) 250 CC 1.513
Sulfamethoxazole-Trimethoprim 400-80 MG 0.582
Vasopressin 20 UNITS 204.544

ASP (Average Sale Price) Drug Pricing History